ranbaxy laboratories ltd strong generic drug sales in u s drive profit higher ranbaxy laboratories ltd said fourth quarter net profit more than doubled thanks to strong generic drug sales in the u s indias largest pharmaceuticals company by sales also said it will begin due diligence early next month on a possible acquisition of merck kgaas generics unit which the german pharmaceuticals and chemicals company is considering selling ranbaxy chief executive and managing director malvinder singh said the move was in line with its strategy to grow through acquisitions globally but declined to put a value on the merck unit ranbaxys net jumped to billion rupees &# million from million rupees a year earlier while net sales rose to billion rupees 
